Stephen Smolinski

Insider Reports History

Location
Watertown, MA
Signature
/s/ Christopher Sullivan, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen Smolinski:

Company Role Class Num Shares Value Price $ Report Date Ownership
Avalo Therapeutics, Inc. Chief Commercial Officer Stock Option (Right to Buy) 400,000 04 Jan 2022 Direct

Insider Reports Filed by Stephen Smolinski

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AVTX Avalo Therapeutics, Inc. 04 Jan 2022 1 $0 4 Chief Commercial Officer 06 Jan 2022, 15:19
AVTX Avalo Therapeutics, Inc. 03 Jan 2022 0 $0 3 Chief Commercial Officer 06 Jan 2022, 15:16